ClearCut Surgical Raises $3.7 Million in Seed Funding to Advance New Electrosurgery Device

BOSTON – JANUARY 21, 2026 – ClearCut Surgical, a medical device company developing a new smoke evacuation electrosurgery device, announced the successful closure of $3.7 million in an oversubscribed Series Seed Preferred round.

The company’s multifunctional, plug-and-play, single-use disposable electrosurgery device integrates with existing hospital infrastructure for on-demand liquid suction and continuous smoke evacuation. The round was led by MassVentures with additional participation from Launchpad Venture Group, Angel Investor Forum, AIF Seed Fund V, eCoast Angels, Harvard Business School Angels, and Imbolc Partners.

The funding will support the commercial device build, certification testing, regulatory submission, and initial commercialization efforts.

ClearCut Surgical’s proprietary and patented four-in-one device was invented by two surgeons in Boston who experienced firsthand the limitations and ergonomic challenges of existing electrosurgery devices. The device combines electrosurgery, on-demand liquid suction, continuous smoke evacuation, and on-demand blunt dissection functions into a single-use disposable device.

In conjunction with the financing, ClearCut Surgical announced the appointment of Paul Hermes as chairman of the board. Mr. Hermes brings more than three decades of leadership in surgical device innovation, product development, and commercialization across global medical device organizations.

He previously served as Chief Technology Officer for Covidien’s Medical Device franchise, overseeing multiple global R&D organizations, including Valleylab, during a period that fundamentally reshaped the energy and electrosurgery landscape. He later founded and led Medtronic’s Hugo robotic-assisted surgery program through its formative development phase and most recently served as chairman of BioRez, which was acquired by CONMED.

“Electrosurgery is one of the most widely used tools in surgery, yet surgeons continue to work around longstanding limitations that affect efficiency and visibility,” said Mr. Hermes. “ClearCut Surgical brings electrosurgery, on-demand liquid suction, continuous smoke evacuation, and on-demand blunt dissection together at the surgeon’s fingertips in a single-use device.”

Vinit Nijhawan, Managing Director at MassVentures, also joined the board, bringing deep experience in early-stage company formation and growth.

Mr. Nijhawan has over 30 years of experience building startups, three of which were acquired by Boeing, Motorola and Qualcomm. He currently teaches entrepreneurship at Boston University in addition to his role advising and investing in startups at MassVentures.

“Led by an experienced CEO with a strong track record in medical device commercialization and grounded in surgeon-driven insight, ClearCut Surgical has a clear path toward regulatory clearance and adoption,” said Mr. Nijhawan.

“Surgeons should not have to manage multiple tools and extra hands to perform routine procedures. Our device was invented by surgeons for surgeons to address these frustrations and inefficiencies,” said Jeff Caputo, CEO of ClearCut Surgical. “We are thrilled by the support from our investors and strong interest from surgeons. This financing will allow us to complete product development, pursue 510(k) clearance, and bring this innovative solution to market.”

About ClearCut Surgical

ClearCut Surgical is a Massachusetts-based medical device company developing a next-generation electrosurgery device designed to simplify surgical workflows. Co-founded by Alex Yang, MD, Heung Bae Kim, MD, and General Inception, its single-use device combines electrosurgery, on-demand liquid suction, continuous smoke evacuation, and on-demand blunt dissection.

ClearCut Surgical is advancing its device toward U.S. Food and Drug Administration 510(k) clearance and initial commercialization.

Media Contact

Andrea Vuturo
Vuturo Group for ClearCut Surgical
andrea@vuturo.com
+1 (415) 689-8414